The way countries like Denmark are completely relaxing all restrictions now makes me doubt that RATs will be used much in future, unless another strain of Covid that is quite severe (like Delta) starts somewhere.
Even if the need for RAT testing for Covid evaporates, EuGeni should still have a viable future IF ADO can develop the new tests such as cardiac troponin and sepsis. (A big dark horse for me is a test for concussion...should be snapped up by the military and football. But again, the need for a reader could dampen takeup for military field operations.)
Ann: Quarterly Update / Appendix 4C, page-241
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.003(11.5%) |
Mkt cap ! $72.20M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.7¢ | 2.9¢ | $1.433M | 44.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 870964 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 511263 | 4 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |